Strs Ohio Celldex Therapeutics, Inc. Transaction History

Strs Ohio

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$32.76 - $42.56 $22,932 - $29,792	700 Added 11.86%	6,600 $244,000
Q1 2024 May 13, 2024	BUY	$35.22 - $51.88 $112,704 - $166,016	3,200 Added 118.52%	5,900 $247,000
Q4 2023 Jan 30, 2024	BUY	$22.61 - $40.65 $29,393 - $52,845	1,300 Added 92.86%	2,700 $107,000
Q3 2023 Oct 26, 2023	SELL	$25.45 - $37.46 $129,795 - $191,046	-5,100 Reduced 78.46%	1,400 $38,000
Q2 2023 Jul 31, 2023	BUY	$30.29 - $38.28 $15,145 - $19,140	500 Added 8.33%	6,500 $220,000
Q1 2023 Aug 02, 2023	SELL	$34.78 - $47.43 $17,390 - $23,715	-500 Reduced 7.69%	6,000 $215,000
Q1 2023 Apr 27, 2023	BUY	$34.78 - $47.43 $166,944 - $227,664	4,800 Added 400.0%	6,000 $215,000
Q4 2022 Jan 26, 2023	BUY	$27.78 - $45.38 $33,336 - $54,456	1,200 New	1,200 $53,000
Q1 2022 Apr 21, 2022	SELL	$27.64 - $39.32 $174,132 - $247,716	-6,300 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$28.95 - $55.99 $182,385 - $352,737	6,300 New	6,300 $340,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.1B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.